Antibody-mediated delivery of a viral MHC-I epitope into the cytosol of target tumor cells repurposes virus-specific CD8(+) T cells for cancer immunotherapy

BACKGROUND: Redirecting pre-existing virus-specific cytotoxic CD8(+) T lymphocytes (CTLs) to tumors by simulating a viral infection of the tumor cells has great potential for cancer immunotherapy. However, this strategy is limited by lack of amenable method for viral antigen delivery into the cytoso...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Keunok, Son, Min-Jeong, Lee, Se-Young, Kim, Jeong-Ah, Ko, Deok-Han, Yoo, Sojung, Kim, Chul-Ho, Kim, Yong-Sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027861/
https://www.ncbi.nlm.nih.gov/pubmed/35459256
http://dx.doi.org/10.1186/s12943-022-01574-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027861/
https://www.ncbi.nlm.nih.gov/pubmed/35459256
http://dx.doi.org/10.1186/s12943-022-01574-0

Ejemplares similares